CELS Canada in the Valley Showcase
Save the Date: April 8th & 9th 2025
The CELS Canada in the Valley Showcase brings together some of the most promising Canadian Health & Life Sciences companies that are scaling and commercializing in the US for two immersive days in Silicon Valley. Highlights include:
2 days of programming and networking in Silicon Valley
60 CELS Valley Ready alumni and other promising life science startups from across Canada and various industry sub-sectors are invited to join
Curated investor and strategic partner meetings
Business roundtables & keynote speakers
High-value networking with local investors, influencers, executives, and startup leaders
Recruitment for the Canada in the Valley Showcase 2025 planning committee is officially open!
On April 8th & 9th, 2025, we’re hosting the 4th Canada in the Valley Showcase in the San Francisco Bay Area, spotlighting Canada’s brightest early-stage Life Science companies. The event will connect them with top-tier investors, industry leaders, and strategic partners, and we’d love for you to be part of this incredible journey.
We’re building a Showcase Planning Committee and are seeking passionate, driven individuals like you to help make this event extraordinary. By contributing just 2–4 hours a month, you can:
Support emerging innovators and connect with top industry leaders.
Help us shape an inspiring event by identifying key speakers and contributors.
This is a great chance to make a lasting impact on life science innovation, and we’d love to have your expertise!
Past Programs
Trends in Life Science Investing and Dealmaking with Chris Dokomajilar @ DealForma
Panel on AI in Health with Kiersten Stead @ DCVC, Brad Genereaux @ Nvidia, Bruce Meadows @ Takeda Digital Ventures, Angele Maki @ Hummingbird Bioscience
Panel on Investment Strategy in 2024 & Outlook with Rami Hannoush @ Versant Ventures, Nate Chang @ Playground VC, Cedric Bisson @ Teralys Capital, Jennifer Friel Goldstein @ SVB
Strategic Dynamics in Biopharmaceuticals Today with Michael Kingston @ Lazard
Panel on Policy Impact on Healthcare Market Access with Darya Rose @ Gilead, Matt Wetzel @ Goodwin, Richard Ramco @ EY
Generative AI in Healthcare with Gilmer Valdes @ UCSF
What our Past Participants Say
Past Participating Speakers & Mentors
-
Brad Genereaux
Global Lead, Healthcare Alliances @ NVIDIA
-
Nate Chang
Operating Partner @ Playground Global
-
Kiersten Stead
Managing Partner @ DCVC Bio
-
Rami Hannoush
Venture Partner @ Versant Ventures
-
Veronica Cai
Board Member @ CELS
-
Glenn Reicin
CFO @ Alladapt Immunotherapeutics
-
Cedric Bisson
Partner @ Teralys Capital
-
Mark Ginestro
Principal @ EY-Parthenon
-
Angele Maki
Chief Business Officer @ Hummingbird Bioscience
-
Matt Wetzel
Partner Life Sciences Regulatory & Compliance @ Goodwin
-
Ali Samiian
VP regulatory affairs and reimbursement @ Stoparkinson
-
Jennifer Friel Goldstein
Head of Startup Banking, Technology & Life Sciences @ Silicon Valley Bank
-
Darya Rose
Director, Global Value & Access Strategy @ Gilead Sciences
-
Richard Ramko
Partner, US Life Sciences Assurance Leader @ EY
-
Scott St. Germain
Vice President, Oncology, Business General Manager @ Genentech
-
Ron Weissman
Chair, Board of Directors @ Angel Capital Association
-
Michael Kingston
Managing Director @ Lazard
-
Gilmer Valdes
Associate Professor @ UCSF
-
Neil Aubuchon
Chief Commercial Officer @ AbCellera
-
Jessica Holmes
Founder @ Regency Market Access Consulting
-
Partha Ray
Faculty @ Stanford Biodesign
-
Don Vaughn
CEO @ Ampa
-
Rachel Lane
Principal @ Versant Ventures
-
Surbhi Sama
Partner @ Y Combinator
-
Mike Regan
Chief Innovation Officer @ Fogarty Innovation
-
Amr Salahieh
Co-Founder and CEO @ Shifamed
-
Rui Jing Jiang
Founder and CEO @ Avisi Technologies
-
Shiva Amiri
VP, Data and AI @ Pivotal Life Sciences
-
Suresh Pai
Principal @ LamaMed Solutions
-
Chris Dokomajilar
Founder & CEO @ DealForma
-
Bruce Meadows
Managing Partner @ Takeda Digital Ventures
